Emcure Pharmaceuticals has received Establishment Inspection Report (EIR) for its manufacturing facility located at Pune. Further, United States Food & Drug Administration (USFDA) has classified the inspection of the said facility as ‘Voluntary Action Indicated’ (VAI).
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.